Oct 26 (Reuters) - Resverlogix Corp RVX.TO :
* Commences phase 3 clinical trial BETonMACE with Apabetalone
* Apabetalone will be evaluated in a phase 3 clinical trial in high-risk
coronary artery disease and type 2 diabetes mellitus patients
* Source text for Eikon ID:nPnplZ3b
* Further company coverage RVX.TO